Permira

Quotient Sciences Appoints Thierry Van Nieuwenhove as New CEO

Retrieved on: 
Monday, October 16, 2023
Quotient, Investment, The Home Depot, Retirement, Lytx, Drug development, Business, Geraardsbergen, Senior advisor, UPS, Wells Fargo, Growth, API, Novasep, CDMO, Synthesis, Patient, Pharmaceutical industry, Management, Cambrex Corporation, Permira

Van Nieuwenhove succeeds Mark Egerton, who retires after 18 years in the role

Key Points: 
  • Van Nieuwenhove succeeds Mark Egerton, who retires after 18 years in the role
    NOTTINGHAM, England, Oct. 16, 2023 /PRNewswire/ -- Quotient Sciences ("Quotient" or the "Company"), a leading global pharmaceutical drug development and manufacturing accelerator, is pleased to announce the appointment of Thierry Van Nieuwenhove as its new Chief Executive Officer (CEO), effective 16thOctober 2023.
  • Thierry succeeds Mark Egerton who, after 18 years of successfully leading Quotient as CEO, is retiring from executive life.
  • Thierry Van Nieuwenhove joins Quotient with an extensive track record in the pharma/CDMO services industry spanning over 23 years, and with experience in both small molecules and biologics.
  • Thierry Van Nieuwenhove said: "I am honoured to join Quotient as its new CEO and lead a team dedicated to improving the lives of patients worldwide.

Quotient Sciences Appoints Thierry Van Nieuwenhove as New CEO

Retrieved on: 
Monday, October 16, 2023
Quotient, Investment, The Home Depot, Retirement, Lytx, Drug development, Business, Geraardsbergen, Senior advisor, UPS, Wells Fargo, Growth, API, Novasep, CDMO, Synthesis, Patient, Pharmaceutical industry, Management, Cambrex Corporation, Permira

Van Nieuwenhove succeeds Mark Egerton, who retires after 18 years in the role

Key Points: 
  • Van Nieuwenhove succeeds Mark Egerton, who retires after 18 years in the role
    NOTTINGHAM, England, Oct. 16, 2023 /PRNewswire/ -- Quotient Sciences ("Quotient" or the "Company"), a leading global pharmaceutical drug development and manufacturing accelerator, is pleased to announce the appointment of Thierry Van Nieuwenhove as its new Chief Executive Officer (CEO), effective 16thOctober 2023.
  • Thierry succeeds Mark Egerton who, after 18 years of successfully leading Quotient as CEO, is retiring from executive life.
  • Thierry Van Nieuwenhove joins Quotient with an extensive track record in the pharma/CDMO services industry spanning over 23 years, and with experience in both small molecules and biologics.
  • Thierry Van Nieuwenhove said: "I am honoured to join Quotient as its new CEO and lead a team dedicated to improving the lives of patients worldwide.

Rob Chisholm Joins Qatalyst Group as Partner

Retrieved on: 
Wednesday, September 27, 2023
Finance, Banking, Professional Services, Technology, Software, CPP Investment Board, Hellman & Friedman, Frank Quattrone, Investment, Qatalyst Partners, TMT, Microsoft, Intuit, Sale, Judgement, Silver, Goldman Sachs, Tableau, Acquisition, Partner, Cisco, Thoma Bravo, Qualtrics, Growth, Permira, Anaplan, Citrix Systems, Zendesk, Mailchimp, Adobe, Figma, Broadcom Inc., Splunk, Salesforce, RealPage

Qatalyst Group, a leading technology-focused independent investment bank, announced that Rob Chisholm has joined the Firm today as a Partner, expanding Qatalyst’s industry leading software advisory practice.

Key Points: 
  • Qatalyst Group, a leading technology-focused independent investment bank, announced that Rob Chisholm has joined the Firm today as a Partner, expanding Qatalyst’s industry leading software advisory practice.
  • George Boutros, Chief Executive Officer of Qatalyst Group, said: “Having worked across the table from Rob over the years, I am particularly excited to welcome him to the Qatalyst team.
  • Since its founding in March 2008, Qatalyst has advised on over 200 M&A transactions, with total transaction volume of over $650 billion.
  • Qatalyst Group is a technology-focused independent investment bank headquartered in San Francisco, California.

Vega exits stealth with over $8 million in funding to reshape wealth management

Retrieved on: 
Tuesday, September 26, 2023
Elliott Blackstone, Fintech, High-net-worth individual, Citibank, Financial Conduct Authority, Lead, KKR, Blackstone, Goldman Sachs, Investment, FRN, Engineering, GFC, Permira, Financial services, Financial adviser, Casino

"As a new generation of high-net-worth individuals emerges, we are building the financial products and technological infrastructure the wealth management industry needs to serve them," says Alexis Augier, founder and CEO of Vega.

Key Points: 
  • "As a new generation of high-net-worth individuals emerges, we are building the financial products and technological infrastructure the wealth management industry needs to serve them," says Alexis Augier, founder and CEO of Vega.
  • "Our goal is to provide a unified wealth management platform that transforms the experience for end-users while equipping advisors with institutional-grade solutions."
  • These will help wealth advisors and their clients unlock liquidity from — and optimise the management of — complex financial assets.
  • By combining financial expertise with technology, Vega is truly levelling the playing field in wealth management" says Robin Godenrath, Managing Director and Founding Partner at Picus Capital.

Adam Meister Joins Qatalyst Group

Retrieved on: 
Monday, August 14, 2023
Finance, Banking, Professional Services, Other Technology, Technology, Frank Quattrone, Qatalyst Partners, Microsoft, Permira, Intuit, Sale, Judgement, Goldman Sachs, M&A, Slack Technologies, Thoma Bravo, CFO, Growth, Anaplan, Citrix Systems, Mailchimp, Adobe, Figma, Broadcom Inc., Salesforce, Clari

Qatalyst Group, a leading technology-focused independent investment bank, announced today that Adam Meister has joined the Firm as a Managing Director, bolstering Qatalyst’s industry leading software advisory practice.

Key Points: 
  • Qatalyst Group, a leading technology-focused independent investment bank, announced today that Adam Meister has joined the Firm as a Managing Director, bolstering Qatalyst’s industry leading software advisory practice.
  • George Boutros, Chief Executive Officer of Qatalyst Group, said: “Having recently worked with Adam as a client of the firm, I am particularly excited to welcome him to the Qatalyst team.
  • Adam will augment our industry leading team that provides differentiated, high impact advice to established and emerging leaders across the industry.”
    Mr. Meister has over fifteen years of experience in the software ecosystem.
  • Qatalyst Group is a technology-focused independent investment bank headquartered in San Francisco, California.

TG Therapeutics and Neuraxpharm Announce Ex-US Commercialization Agreement for BRIUMVI® (ublituximab-xiiy)

Retrieved on: 
Tuesday, August 1, 2023
DLA, Central nervous system, Civil service commission, PJT Partners, Conference call, Multiple sclerosis, TG, CNS, MS, RMS, Acquisition, Patient, United Kingdom, Therapy, EC, DLA Piper, Piper, Conference, European Commission, Permira, Pharmaceutical industry, EU

Conference call to be held today, August 1, 2023 at 8:30 AM ETNEW YORK and DÜSSELDORF, Germany, Aug. 01, 2023 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) (TG) and Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, today announced an agreement for the ex-US commercialization of BRIUMVI® (ublituximab). BRIUMVI is the first and only anti-CD20 monoclonal antibody approved in the United States (US) and European Union (EU) for adult patients with relapsing forms of multiple sclerosis (RMS) that can be administered in a one-hour infusion, twice a year, following the starting dose. Neuraxpharm is backed by funds advised by the global private equity firm, Permira.

Key Points: 
  • Additionally, TG Therapeutics retains an option to buy back all rights under the commercialization agreement for a period of two years in the event of a change in control of TG.
  • J.P. Morgan Securities LLC served as exclusive financial advisor for TG Therapeutics, Inc. and DLA Piper provided legal counsel.
  • TG Therapeutics will discuss this announcement on a previously announced second quarter 2023 conference call today at 8:30 AM ET.
  • In order to participate in the conference call, please call 1-877-407-8029 (U.S.), 1-201-689-8029 (outside the U.S.), Conference Title: TG Therapeutics.

Professors Without Borders calls for donations and volunteers, announcing changes to its Board of Trustees

Retrieved on: 
Friday, July 7, 2023
Learning, Poverty, Unemployment, University, Student, Education, RMIT University, Harvard University, Alfa Financial Software, Woman, Trustee, Mentorship, Health, Srinakharinwirot University, University of Johannesburg, Investment, Big Society Capital, Chair, Permira, Nursing, Management

LONDON, July 7, 2023 /PRNewswire/ -- Professors Without Borders, a UK-registered charity that works to improve equitable access to quality education, is delighted to announce changes to the Board.

Key Points: 
  • LONDON, July 7, 2023 /PRNewswire/ -- Professors Without Borders, a UK-registered charity that works to improve equitable access to quality education, is delighted to announce changes to the Board.
  • The board of trustees has welcomed Andrew Denton , CEO of Alfa Financial Software, as their new Chair.
  • Professors Without Borders is delighted to add two new Trustees to its team.
  • Professors Without Borders transforms education by bringing equitable, high-quality learning experiences to students and educators in their home environments.

The Knot Worldwide Welcomes Marketing and Consumer Technology Leader Carolyn Everson to its Board of Directors

Retrieved on: 
Monday, June 26, 2023
Bridal, Retail, The Coca-Cola Company, Advertising, Viacom, Columbia University Vagelos College of Physicians and Surgeons, Gen, Meta, Permira, Policy, Jefferson Literary and Debating Society, Everson, Microsoft, The Knot Worldwide, Council, Generation Z, Villanova University, Name, M.B.A, Foreign policy, Harvard Business School, Senior advisor, Humane society, Knot, Family, The Walt Disney Company, Management, Instacart

The Knot Worldwide , a leading global marketplace and family of brands championing celebration, announced today that Carolyn Everson has joined the organization’s board of directors , effective March 22, 2023.

Key Points: 
  • The Knot Worldwide , a leading global marketplace and family of brands championing celebration, announced today that Carolyn Everson has joined the organization’s board of directors , effective March 22, 2023.
  • Everson brings over 28 years of experience to The Knot Worldwide’s board, including having held executive and advisory roles at global consumer businesses.
  • Most recently, Everson served as President of Instacart, where she oversaw the fast-growing company’s advertising, partnerships, policy and legal teams.
  • “I’m incredibly excited to be a part of The Knot Worldwide’s board during a time when the wedding industry is reaching an inflection point,” said Carolyn Everson.

Safe Harbor Equity Announces Appointment of Neal Howe

Retrieved on: 
Friday, June 2, 2023
Distress, Business development, CIO, Permira, Barclays, Financial services

This hire coincides with the launch of Safe Harbor Equity's 4th Distressed CRE Debt Fund on June 1st.

Key Points: 
  • This hire coincides with the launch of Safe Harbor Equity's 4th Distressed CRE Debt Fund on June 1st.
  • Safe Harbor Equity, has expanded its team with the hiring of Neal Howe as Senior Director, Business Development.
  • "At Safe Harbor Equity, I will be utilizing my experience to provide institutional investors with additional sources of alpha and diversification," states Mr. Howe.
  • "Neal brings a tremendous amount of firepower to our team and will assist Safe Harbor Equity in providing best-in-class financial advice to our clients," states Rafael Serrano, Founder and CIO of Safe Harbor Equity.

Moonfare Core Portfolio II closes at milestone €100m+ in capital

Retrieved on: 
Tuesday, May 16, 2023
Personal Finance, Finance, Professional Services, Asset Management, Fintech, Heart, Core, Lexington Partners, EQT, Pulse, Permira, Investment, Geography, Fine chemical, Cryptocurrency, Financial services

Global private equity platform Moonfare has hit a strategic milestone with the final close of its second core portfolio, Moonfare Core Portfolio II (Core II), which surpassed its fundraising target, propelling a proprietary Moonfare portfolio beyond the €100m mark for the first time.

Key Points: 
  • Global private equity platform Moonfare has hit a strategic milestone with the final close of its second core portfolio, Moonfare Core Portfolio II (Core II), which surpassed its fundraising target, propelling a proprietary Moonfare portfolio beyond the €100m mark for the first time.
  • Designed to sit at the heart of an individual’s private investments portfolio, it offers access to buyout and buyout-related strategies, such as secondaries and co-investments, one of the most established areas of private equity.
  • Pauls said, “Top-flight buyout funds have historically offered high risk-adjusted returns, with higher returns and lower volatility than public equity markets.
  • The portfolio’s first vintage, Moonfare Core Portfolio I, closed in 2020 at €75m, 50% over target.